The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.
Saved in:
| Title: | The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2. |
|---|---|
| Authors: | Watts NR; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America., Eren E; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America., Palmer I; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America., Huang PL; Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, United States of America., Huang PL; Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, United States of America., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, NCI, NIH, Bethesda, Maryland, United States of America., Lee-Huang S; Department of Biochemistry and Molecular Pharmacology, New York University, Grossman School of Medicine, New York, New York, United States of America., Wingfield PT; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America. |
| Source: | PloS one [PLoS One] 2023 Jun 29; Vol. 18 (6), pp. e0286370. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
